Loading data
CCCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.06 bn USD | 944.8 m USD | 866.38 m USD | 782.45 m USD | 688.29 m USD |
| Cost of revenue | 280.19 m USD | 231 m USD | 230.22 m USD | 213.94 m USD | 195.66 m USD |
| Gross profit | 776.81 m USD | 713.8 m USD | 636.16 m USD | 568.51 m USD | 492.63 m USD |
| Research and development expense | 227.5 m USD | 201.49 m USD | 173.11 m USD | 156.96 m USD | 165.99 m USD |
| Operating profit | 93.84 m USD | 80.11 m USD | -23.93 m USD | 51.92 m USD | -144.68 m USD |
| Interest expense | 71.01 m USD | 64.61 m USD | 63.58 m USD | 38.99 m USD | 58.99 m USD |
| Profit before tax | 21.53 m USD | 44.31 m USD | -84.55 m USD | 49.86 m USD | -274.92 m USD |
| Income tax expense | 19.84 m USD | 13.07 m USD | 5.52 m USD | 11.46 m USD | -26 m USD |
| Net income (reported basis) | 1.69 m USD | 31.24 m USD | -90.07 m USD | 38.41 m USD | -248.92 m USD |
| Net income attributable to common shareholders | 412 k USD | 26.15 m USD | -92.48 m USD | 38.41 m USD | -248.92 m USD |
| Basic earnings per share | 0 USD/share | 0.04 USD/share | -0.15 USD/share | 0.06 USD/share | -0.46 USD/share |
| Diluted earnings per share | 0 USD/share | 0.04 USD/share | -0.15 USD/share | 0.06 USD/share | -0.46 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.